BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12668980)

  • 1. Microdissection-based allelotyping discriminates de novo tumor from intrahepatic spread in hepatocellular carcinoma.
    Finkelstein SD; Marsh W; Demetris AJ; Swalsky PA; Sasatomi E; Bonham A; Subotin M; Dvorchik I
    Hepatology; 2003 Apr; 37(4):871-9. PubMed ID: 12668980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotyping of hepatocellular carcinoma in liver transplant recipients adds predictive power for determining recurrence-free survival.
    Marsh JW; Finkelstein SD; Demetris AJ; Swalsky PA; Sasatomi E; Bandos A; Subotin M; Dvorchik I
    Liver Transpl; 2003 Jul; 9(7):664-71. PubMed ID: 12827550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of accumulated allele loss between primary tumor and lymph node metastasis in stage II non-small cell lung carcinoma: implications for the timing of lymph node metastasis and prognostic value.
    Sasatomi E; Finkelstein SD; Woods JD; Bakker A; Swalsky PA; Luketich JD; Fernando HC; Yousem SA
    Cancer Res; 2002 May; 62(9):2681-9. PubMed ID: 11980668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic classification of combined hepatocellular-cholangiocarcinoma.
    Fujii H; Zhu XG; Matsumoto T; Inagaki M; Tokusashi Y; Miyokawa N; Fukusato T; Uekusa T; Takagaki T; Kadowaki N; Shirai T
    Hum Pathol; 2000 Sep; 31(9):1011-7. PubMed ID: 11014564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fractional allelic loss in non-end-stage cirrhosis: correlations with hepatocellular carcinoma development during follow-up.
    Roncalli M; Bianchi P; Grimaldi GC; Ricci D; Laghi L; Maggioni M; Opocher E; Borzio M; Coggi G
    Hepatology; 2000 Apr; 31(4):846-50. PubMed ID: 10733538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative genomic hybridization (CGH) and fluorescence in situ hybridization (FISH) in the diagnosis of hepatocellular carcinoma.
    Wilkens L; Bredt M; Flemming P; Mengel M; Becker T; Klempnauer J; Kreipe H
    J Hepatobiliary Pancreat Surg; 2002; 9(3):304-11. PubMed ID: 12353141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fractional allelic imbalance could allow for the development of an equitable transplant selection policy for patients with hepatocellular carcinoma.
    Dvorchik I; Schwartz M; Fiel MI; Finkelstein SD; Marsh JW
    Liver Transpl; 2008 Apr; 14(4):443-50. PubMed ID: 18266211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microdissection genotyping analysis of the effect of intraarterial cytoreductive chemotherapy in the treatment of lacrimal gland adenoid cystic carcinoma.
    Tse DT; Finkelstein SD; Benedetto P; Dubovy S; Schiffman J; Feuer WJ
    Am J Ophthalmol; 2006 Jan; 141(1):54-61. PubMed ID: 16386976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microdissection-based mutational genotyping of serous borderline tumors of the ovary.
    Krishnamurti U; Sasatomi E; Swalsky PA; Jones MW; Finkelstein SD
    Int J Gynecol Pathol; 2005 Jan; 24(1):56-61. PubMed ID: 15626917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation.
    Facciuto ME; Koneru B; Rocca JP; Wolf DC; Kim-Schluger L; Visintainer P; Klein KM; Chun H; Marvin M; Rozenblit G; Rodriguez-Davalos M; Sheiner PA
    Ann Surg Oncol; 2008 May; 15(5):1383-91. PubMed ID: 18320284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma.
    Pan HW; Ou YH; Peng SY; Liu SH; Lai PL; Lee PH; Sheu JC; Chen CL; Hsu HC
    Cancer; 2003 Jul; 98(1):119-27. PubMed ID: 12833464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular changes in hepatocellular dysplastic nodules on microdissected liver biopsies.
    Maggioni M; Coggi G; Cassani B; Bianchi P; Romagnoli S; Mandelli A; Borzio M; Colombo P; Roncalli M
    Hepatology; 2000 Nov; 32(5):942-6. PubMed ID: 11050043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.
    Bozorgzadeh A; Orloff M; Abt P; Tsoulfas G; Younan D; Kashyap R; Jain A; Mantry P; Maliakkal B; Khorana A; Schwartz S
    Liver Transpl; 2007 Jun; 13(6):807-13. PubMed ID: 17539001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor origin of de novo hepatocellular carcinoma in hepatic allografts.
    Flemming P; Tillmann HL; Barg-Hock H; Kleeberger W; Manns MP; Klempnauer J; Kreipe HH
    Transplantation; 2003 Dec; 76(11):1625-7. PubMed ID: 14702536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-density allelotyping of chromosome 8p in hepatocellular carcinoma and clinicopathologic correlation.
    Chan KL; Lee JM; Guan XY; Fan ST; Ng IO
    Cancer; 2002 Jun; 94(12):3179-85. PubMed ID: 12115350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.
    Shimoda M; Ghobrial RM; Carmody IC; Anselmo DM; Farmer DG; Yersiz H; Chen P; Dawson S; Durazo F; Han S; Goldstein LI; Saab S; Hiatt J; Busuttil RW
    Liver Transpl; 2004 Dec; 10(12):1478-86. PubMed ID: 15558585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular prediction of early recurrence after resection of hepatocellular carcinoma.
    Yoshioka S; Takemasa I; Nagano H; Kittaka N; Noda T; Wada H; Kobayashi S; Marubashi S; Takeda Y; Umeshita K; Dono K; Matsubara K; Monden M
    Eur J Cancer; 2009 Mar; 45(5):881-9. PubMed ID: 19167881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recurrence and metastasis of hepatocellular carcinoma after liver transplantation: single center experiences].
    Zheng SS; Chen J; Wang WL; Zhang M; Shen Y; Wu J; Xu X; Yan S
    Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(21):1609-13. PubMed ID: 19094751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of immunosuppression.
    Vivarelli M; Cucchetti A; Piscaglia F; La Barba G; Bolondi L; Cavallari A; Pinna AD
    Liver Transpl; 2005 May; 11(5):497-503. PubMed ID: 15838913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors and patterns of recurrence after resection of hepatocellular carcinoma.
    Cha C; Fong Y; Jarnagin WR; Blumgart LH; DeMatteo RP
    J Am Coll Surg; 2003 Nov; 197(5):753-8. PubMed ID: 14585409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.